Coronary Bioresorbable Vascular Scaffolds: Any Chance of Resurrection?

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Grant Support/Research Contract - 4C Medical; Terumo Medical Corporation; Bristol-Myers Squibb; Edwards Lifesciences; Advanced Nano Technologies; Adriakaim; Reflow Medical; Tenaya Therapeutics; Shape Memory Medical; Occlutech; Neochord; Lungpacer; InnovHeart; Deinde Medical; Ancora Heart; Cardiac Implants; Dura Biotech; Mitria; InQB8; Ethicon; R3 Vascular; Puzzle Medical; ReCardia; StrideBio; VivaSure; Magenta Medical; Canon; Thubrikar Aortic Valve; Cardiovascular Systems, Inc.; Acotec Scientific; Microbot; Philips; Zoll; Cook Medical; Medtronic; ReValve Medical; Orchestra Biomed; Microtech; Motus GI; MicroVention; Takeda Pharmaceuticals; Encompass Technologies; Retriever Medical; Siemens Healthineers; Trisol Medical; IntraTech; Abbott; Bayliss Medical; Dropshot Therapeutics; Abiomed; Autonomix; UltraVet; Meacor; JensCare; Mitre Medical; 3D Systems